| |
|
| Remuneration report |
| |
Executive remuneration
for the company is determined and monitored by the Remuneration
Committee which comprises five non-executive directors. The
committee has set the Executive Remuneration Policy for AngloGold
as follows: |
| |
| • |
to attract, reward
and retain executives of the highest calibre; |
| • |
to align the behaviour
and performance of executives with the company’s
strategic goals and in the overall interests of shareholders; |
| • |
to ensure the
appropriate mix of short-, medium- and long-term rewards
and incentives, with the latter being closely linked
to structured company performance targets and strategic
objectives; and |
| • |
to ensure that,
within regions, management is competitively rewarded
within a global remuneration policy, which recognises
both local and global markets. |
|
| |
| In particular the Remuneration Committee
is responsible for: |
| • |
the specific remuneration
packages for executive directors of the company including
basic salary, performance-based short- and long-term
incentives, pensions, and other benefits; and |
| • |
the operation
of the company’s share option scheme. |
|
| |
| Membership of the Remuneration Committee |
| The Remuneration Committee
has included the following non-executive directors during
the period since the previous annual general meeting: |
| |
| • |
Russell Edey (Chairman) |
| • |
Colin Brayshaw (appointed July 2003) |
| • |
Nicky Oppenheimer |
| • |
Julian Ogilvie Thompson |
| • |
Tony Trahar |
|
| |
The committee met three
times during 2003. The chief executive officer and the executive
officer responsible for human resources attend the meetings
but are not present when their own benefits are discussed.
During the year, advice was received from Deloitte and Touche
LLP following a survey they conducted on AngloGold’s
behalf of best practices in executive remuneration in the
global resources sector, with particular emphasis on gold
mining.
The following principles are used in the determination of
executive remuneration: |
| |
| 1. |
Annual remuneration
should be a combination of base pay and short-, medium-
and long-term incentives, with salary comprising about
50% of annual remuneration. |
| 2. |
Salary, should
be set at the median for the relevant competitive markets. |
| 3. |
All incentive
plans should align performance targets with shareholder
interests. |
|
| |
| Currently, executive director remuneration
comprises the following elements: |
| |
| 1. |
Salary
which is subject to annual review by the Remuneration
Committee and is set at the median of salaries in the
relevant competitive markets in South Africa and globally.
The individual salaries of executive directors are reviewed
in light of their own performance, experience, responsibility
and company performance. |
| 2. |
Annual
bonus, which is determined by the achievement
of a set of company and individual performance targets.
The company targets include earnings per share, cost
control and global production. The weighting of the
respective contribution of company and individual targets
is 70% for company and 30% for individual. The Remuneration
Committee has the right to adjust the overall level
of bonus of executive directors, particularly in the
light of the company’s annual safety performance
and of the specific contribution of individual executive
directors to the company’s success. |
| 3. |
Share
option scheme, which allows for an annual grant
of AngloGold share options based on the achievement
of pre-determined performance targets similar to those
used for the annual bonus. Options granted are subject
to the achievement of a performance condition set by
the Remuneration Committee, and are subject to a maximum
equivalent to annual salary for any executive director. |
| 4. |
Pensions:
all executive directors are members of the AngloGold
Pension Fund, a defined benefit fund which guarantees
a pension on retirement equivalent to 2% of final basic
salary per year of service. Death and disability cover
reflects best practice amongst comparable employers
in South Africa. |
| 5. |
Other
benefits: executive directors are members of
the AngloGold Medical Scheme, which covers the director
and his immediate family. |
|
| |
| Long-term incentive plan |
| The committee resolved
to investigate the introduction of a long-term incentive plan
in 2005, subject to shareholder approval. |
| |
| Directors’ service contracts |
| Service contracts of
executive directors are reviewed annually. The contractual
notice period in respect of Bobby Godsell, as chief executive
officer, is 12 months, and for the other three executive directors,
six months. The contracts also deal with compensation if employment
is terminated or a material change in role, responsibilities
or remuneration occurs. Compensation in these circumstances
is pegged at twice the notice period. |
| |
| Directors’ emoluments |
| The salaries and benefits
of executive directors, who receive no fees as members of
the AngloGold Board, and the fees paid to non-executive directors,
are shown in the tables on pages 64 to 66. |
| |
| Non-executive directors’ remuneration |
| The remuneration and
fees of non-executive board members are reviewed from time
to time to ensure that they remain competitive and that they
attract individuals of the appropriate reputation and experience
to the board. The executive directors are responsible for
conducting this review and making recommendations accordingly.
To this end, at the annual general meeting to be held on Thursday,
29 April 2004, shareholders will be requested to consider
an ordinary resolution to approve the following: |
| |
| • |
an increase in
the fees payable to directors of the company from R100,000
to R110,000 per annum, provided that directors who are
non-residents of South Africa will receive US$16,000
per annum; |
| • |
an increase in
the fee payable to the deputy chairman of the board
from R150,000 to R300,000 per annum; |
| • |
an increase in
the fee payable to the chairman of the board from R200,000
to US$130,000 per annum, provided that the chairman
is a non-resident of South Africa; and |
| • |
an increase from
US$2,000 to US$4,000 in the additional travel allowance
payable to directors who travel internationally to attend
board meetings. |
|
| |
| All figures have been stated to the nearest
R000. |
| |
| |
Salary |
Per-
formance
related
payments |
Pension
scheme
contri-
butions |
Other
benefits |
Sub-
total |
Pre-tax
gains
on share
options
exercised |
Total |
| Executive Directors? remuneration
2003 |
|
|
|
|
|
|
|
| R M Godsell (Chief Executive Officer) |
5,386 |
2,459 |
684 |
120 |
8,649 |
? |
8,649 |
| J G Best |
2,862 |
857 |
365 |
53 |
4,137 |
4,932 |
9,069 |
| D L Hodgson |
2,862 |
857 |
365 |
61 |
4,145 |
1,845 |
5,990 |
| K H Williams |
2,972 |
927 |
380 |
102 |
4,381 |
291 |
4,672 |
| Total |
14,082 |
5,100 |
1,794 |
336 |
21,312 |
7,068 |
28,380 |
| Executive Directors? remuneration
2002 |
|
|
|
|
|
|
|
| R M Godsell (Chief Executive Officer) |
4,217 |
1,295 |
496 |
283 |
6,291 |
? |
6,291 |
| J G Best |
2,476 |
928 |
300 |
32 |
3,736 |
2,130 |
5,866 |
| D L Hodgson |
2,475 |
678 |
300 |
100 |
3,553 |
2,972 |
6,525 |
| K H Williams |
2,673 |
898 |
333 |
150 |
4,054 |
2,154 |
6,208 |
| Total |
11,841 |
3,799 |
1,429 |
565 |
17,634 |
7,256 |
24,890 |
|
| |
| Non-executive Directors' remuneration |
| |
|
2003 |
|
|
|
2002 |
|
|
| |
Directors?
fees |
Committee
fees |
Travel
allowance |
Total |
Directors?
fees |
Committee
fees |
Travel*
allowance |
Total |
| R P Edey (Chairman) |
200 |
130 |
43 |
373 |
160 |
126 |
41 |
327 |
| Dr T J Motlatsi (Deputy Chairman) |
150 |
110 |
17 |
277 |
117 |
107 |
21 |
245 |
| F B Arisman |
100 |
75 |
45 |
220 |
83 |
60 |
41 |
184 |
| Mrs E le R Bradley |
100 |
110 |
17 |
227 |
83 |
107 |
? |
190 |
| C B Brayshaw |
100 |
65 |
17 |
182 |
83 |
47 |
? |
130 |
| Dr V K Fung (resigned 30 April 2003) |
33 |
10 |
? |
43 |
83 |
30 |
20 |
133 |
| A W Lea |
100 |
30 |
? |
130 |
83 |
28 |
? |
111 |
| W A Nairn |
100 |
110 |
? |
210 |
83 |
104 |
? |
187 |
| J Ogilvie Thompson |
100 |
30 |
? |
130 |
83 |
30 |
? |
113 |
| N F Oppenheimer |
100 |
30 |
? |
130 |
83 |
30 |
? |
113 |
| A J Trahar |
100 |
30 |
? |
130 |
83 |
30 |
? |
113 |
| Total |
1,183 |
730 |
139 |
2,052 |
1,024 |
699 |
123 |
1,846 |
|
| |
|
| |
Directors?
fees |
Committee
fees |
Travel
allowance |
Total |
Directors?
fees |
Committee
fees |
Travel*
allowance |
Total |
| Alternates |
|
|
|
|
|
|
|
|
| D D Barber |
? |
? |
17 |
17 |
? |
? |
? |
? |
| P G Whitcutt |
? |
15 |
? |
15 |
? |
30 |
? |
30 |
| Total |
? |
15 |
17 |
32 |
? |
30 |
? |
30 |
| Fees paid to a former non-executive
director |
|
|
|
|
|
|
|
|
| D M J Ncube |
? |
? |
? |
? |
? |
60** |
? |
60 |
| Total |
? |
? |
? |
? |
? |
60 |
? |
60 |
| Grand
total |
1,183 |
745 |
156 |
2,084 |
1,024 |
789 |
123 |
1,936 |
|
| * |
Introduced with effect from 1 May 2002. |
| ** |
Prior years’ adjustment. |
|
| |
| Executive directors do not receive payment
of directors’ fees and committee fees. |
| |
| Share incentive scheme |
Options to subscribe
for ordinary shares in the company granted to, and exercised
by, executive directors, executive officers and managers during
the year to 31 December 2003, and subsequent to year end,
are included in the table below: |
| |
| Executive
directors and senior management |
|
| |
|
R
M
Godsell |
J
G
Best |
D
L
Hodgson |
K
H
Williams |
Total |
Executive
officers |
Other
managers |
Total |
| Granted as at 1 January 2003 |
|
|
|
|
|
|
|
|
|
| Number |
|
194,300 |
74,100 |
83,700 |
82,100 |
434,200 |
225,600 |
2,678,580 |
3,338,380 |
| Average exercise price per share |
? R |
123.80 |
141.10 |
152.15 |
129.98 |
133.39 |
173.74 |
196.12 |
186.45 |
| Granted during year |
|
|
|
|
|
|
|
|
|
| Number |
|
16,000 |
10,500 |
10,500 |
10,500 |
47,500 |
24,000 |
1,168,200 |
1,239,700 |
| Average exercise price per share |
? R |
221.90 |
221.90 |
221.90 |
221.90 |
221.90 |
221.90 |
221.90 |
221.90 |
| Exercised during year |
|
|
|
|
|
|
|
|
|
| Number |
|
? |
25,800 |
9,600 |
1,500 |
36,900 |
58,200 |
412,920 |
508,020 |
| Average exercise price per share |
? R |
? |
104.96 |
104.00 |
104.00 |
104.67 |
163.21 |
119.10 |
123.10 |
| Average market price per share at
date of exercise |
? R |
? |
296.11 |
296.18 |
297.87 |
296.20 |
271.97 |
285.82 |
284.99 |
| Pre-tax gain at date of exercise |
? R value |
? |
4,931,703 |
1,844,955 |
290,808 |
7,067,466 |
6,329,730 |
68,841,924 |
82,239,120 |
| |
? average |
|
|
|
|
|
|
|
|
| |
R per share |
? |
191.15 |
192.18 |
193.87 |
191.53 |
108.76 |
166.72 |
161.88 |
| Lapsed during year |
|
|
|
|
|
|
|
|
|
| Number |
|
? |
? |
? |
? |
? |
16,000 |
134,100 |
150,100 |
| Average exercise price per share |
? R |
? |
? |
? |
? |
? |
159.60 |
245.47 |
236.32 |
| Held as at 31 December 2003 |
|
|
|
|
|
|
|
|
|
| Number |
|
210,300 |
58,800 |
84,600 |
91,100 |
444,800 |
175,400 |
3,299,760 |
3,919,960 |
| Average exercise price per share |
? R |
131.27 |
171.38 |
166.27 |
141.00 |
145.22 |
185.12 |
212.88 |
203.96 |
| Latest expiry date |
|
2
May |
2
May |
2
May |
2
May |
|
2
May |
2
May |
|
| |
|
2013 |
2013 |
2013 |
2013 |
|
2013 |
2013 |
|
|
| |
| Executive
directors and senior management |
|
| |
|
R
M
Godsell |
J
G
Best |
D
L
Hodgson |
K
H
Williams |
Total |
Executive
officers |
Other
managers |
Total |
| Subsequent to year-end |
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
|
|
|
|
|
|
| Number |
|
? |
? |
? |
? |
? |
? |
? |
? |
| Average exercise price per share |
? R |
? |
? |
? |
? |
? |
? |
? |
? |
| Value |
? R |
|
|
|
|
|
|
|
|
| Exercised |
|
|
|
|
|
|
|
|
|
| Number |
|
? |
? |
? |
30,000 |
30,000 |
? |
73,200 |
103,200 |
| Average exercise price per share |
? R |
? |
? |
? |
104.00 |
104.00 |
? |
116.99 |
113.21 |
| Value |
? R |
|
|
|
3,120,000 |
3,120,000 |
|
8,563,520 |
11,683,520 |
| |
|
|
|
|
|
|
|
|
|
| Average market price per share at date
of exercise |
? R |
? |
? |
? |
290.95 |
290.95 |
? |
301.22 |
298.24 |
| Value |
? R |
|
|
|
8,728,607 |
8,728,607 |
|
22,049,566 |
30,778,173 |
| Pre-tax gain at date of exercise |
|
|
|
|
|
|
|
|
|
| Value |
? R |
? |
? |
? |
5,608,607 |
5,608,607 |
? |
13,486,046 |
19,094,653 |
| Average R per share |
|
? |
? |
? |
186.95 |
186.95 |
? |
184.24 |
185.03 |
| Lapsed |
|
|
|
|
|
|
|
|
|
| Number |
|
? |
? |
? |
? |
? |
? |
5,600 |
5,600 |
| Average exercise price per share |
? R |
? |
? |
? |
? |
? |
? |
253.77 |
253.77 |
| Value |
? R |
|
|
|
|
|
|
1,421,120 |
1,421,120 |
| Held as at 24 February 2004 |
|
|
|
|
|
|
|
|
|
| Number |
|
210,300 |
58,800 |
84,600 |
61,100 |
414,800 |
175,400 |
3,220,960 |
3,811,160 |
| Average exercise price per share |
? R |
131.27 |
171.38 |
166.27 |
159.17 |
148.20 |
185.12 |
214.99 |
206.35 |
| Value |
? R |
27,605,600 |
10,077,100 |
14,066,100 |
9,725,100 |
61,473,900 |
32,469,300 |
692,470,980 |
786,414,180 |
| Latest expiry date |
|
2
May |
2
May |
2
May |
2
May |
|
2
May |
2
May |
|
| |
|
2013 |
2013 |
2013 |
2013 |
|
2013 |
2013 |
|
|
| |
|
| |
|
|
|